| Dr Thomas C Chen, MD | |
|
1097 Apono Pl, Hilo, HI 96720-2701 | |
| (808) 959-6549 | |
| (808) 959-6549 |
| Full Name | Dr Thomas C Chen |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1097 Apono Pl, Hilo, Hawaii |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033435508 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MD2495 (Hawaii) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas C Chen, MD 1097 Apono Pl, Hilo, HI 96720-2701 Ph: (808) 959-6549 | Dr Thomas C Chen, MD 1097 Apono Pl, Hilo, HI 96720-2701 Ph: (808) 959-6549 |
News Archive
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
A new British Journal of Dermatology study provides information that may help explain why many people experience eczema and dry skin in the winter.
Allos Therapeutics, Inc. today announced topline results from the Company's randomized Phase 2b investigational trial of FOLOTYN® (pralatrexate injection) versus erlotinib in patients with Stage IIIB/IV (advanced) non-small cell lung cancer (NSCLC) who had received one or two prior systemic treatments including at least one prior platinum-based regimen. The objective of the trial was to estimate the efficacy of FOLOTYN compared to that of erlotinib as assessed by overall survival.
Pure Protein, L.L.C., a biopharmaceutical company specializing in diagnostic and therapeutic reagents for use in immunology research and development, has announced that Chief Scientist William Hildebrand, Ph.D., and his team, have developed soluble Class II human leukocyte antigens (HLA). This represents a significant technology breakthrough that can dramatically impact multiple pharmaceutical and medical sectors and has enormous market potential. Autoimmune disease is a key area of interest for HLA research and product development.
Five globe-trotting, sun-blocking superheroes teach preschoolers about lifelong sun safety in a new curriculum available this summer based on research at The University of Texas MD Anderson Cancer Center.
› Verified 2 days ago
Dr. Jon V Martell, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 808-974-4700 | |
Dr. Douglas Hiroshi Yamashita, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1276 Kinoole St, Hilo, HI 96720 Phone: 808-935-7181 Fax: 808-935-6332 | |
Mrs. Joy Sakai Wilson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 808-932-3395 | |
Dr. Tiffany Ma, M.D., M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 925-487-0372 | |
Dr. Anthony Lim, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1285 Waianuenue Ave, Hilo, HI 96720 Phone: 808-933-0625 Fax: 808-974-6864 | |
Dr. Pradeepta Chowdhury, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Ponahawai St, Ste116, Hilo, HI 96720 Phone: 808-961-3404 Fax: 808-961-5460 |